GADEWAR, M. and LAL, B. (2022) “MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19”, International Journal of Applied Pharmaceutics, 14(1), pp. 100–105. doi: 10.22159/ijap.2022v14i1.43132.